Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpelisib and Nab-Paclitaxel in HER2-Negative Metastatic Breast Cancer
NCT02379247Phase 2Completed
- Sponsor
- Kazmira
- Start
- Feb 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpelisib in breast cancer, sponsored by Kazmira. Started Feb 2015; status: completed.
02
Drugs
alpelisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02379247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02379247.